Do you want to read an article? Please log in or register.
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection
Tuberculosis
RECOMMENDED
Related content
RECOMMENDED
Tuberculosis
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Infect Dis.
Campbell JR, Trajman A, Cook VJ, Johnston JC, Adjobimey M, Ruslami R, Eisenbeis L, Fregonese F, Valiquette C, Benedetti A, Menzies D
doi: 10.1016/S1473-3099(19)30575-4.
RECOMMENDED
TuberculosisFurther Publications
Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study
Lancet Infect Dis.
Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O'Connell AM, Mirza A, Kon OM, Lalvani A, Zenner D
doi: 10.1016/S1473-3099(19)30260-9.
RECOMMENDED
Tuberculosis
Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J.
Ronald LA, FitzGerald JM, Bartlett-Esquilant G, Schwartzman K, Benedetti A, Boivin JF, Menzies D
doi: 10.1183/13993003.02048-2019.
RECOMMENDED
Tuberculosis
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
Lancet Infect Dis.
Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ
doi: 10.1016/S1473-3099(19)30307-X.
Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease
PLoS One.
La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, Dieli F, Caccamo N
doi: 10.1371/
Tuberculosis
Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force
JAMA.
Kahwati LC, Feltner C, Halpern M, Woodell CL, Boland E, Amick HR, Weber RP, Jonas DE
doi: 10.1001/
RECOMMENDED
Tuberculosis
Adverse events associated with weekly short course isoniazid and rifapentine therapy in pediatric patients with latent tuberculosis: a chart and literature review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol
Peck GM, Staat MA, Huang FS, Khalil N, Boyce C, Kohlrieser CM, Schlaudecker EP
doi: 10.1002/ppul.25456
RECOMMENDED
Tuberculosis
Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015
BMC Infect Dis.
Holmberg V, Soini H, Kivelä P, Ollgren J, Ristola M
doi: 10.1186/s12879-
RECOMMENDED
Tuberculosis
Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study
Lancet Child Adolesc Health.
Radtke KK, Dooley KE, Dodd PJ, Garcia-Prats AJ, McKenna L, Hesseling AC, Savic RM
doi: 10.1016/S2352-4642(19)30196-8.